Chaos, but Good Work Life Balance - Avis employé Applications Services Analyst Merck

3,0
20 déc. 2009
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Good work life balance Use of newer technologies Educated workforce Good pay

Inconvénients

Lack of leadership; Mismanagement Matrix organizational structure with no leadership leads to chaos on projects; no one is in charge so many try to take charge and workers are pulled in many different, conflicting directions Lack of communication Inability to effectively manage or implement change; goals are only the goals of senior management, not emplooyees. Management is ineffective in obtaining buy-in from employees. Lack of cooperation among staff; limited sharing of information Lack of shared vision (and lack of communication/promotion of corporate goals) Functions at each step of system life cycle are centralized but workers receive no training Very limited sharing of information among workers; contractors are constantly brought in but are not given background information required to do their jobs. Workers are afraid of being laid off so they hold onto information in an effort to become indispensable.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout